Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Herbal remedies can cause adverse effects and need more safety research.

Dexamethasone speeds up hair loss in mice, while cyclosporin A slows it down.

Finasteride may help treat chronic CSC, improving vision.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Innovative methods are reducing animal testing and improving biomedical research.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Post-COVID-19 hair loss is not linked to vitamin D or quality of life but is linked to hair graying.

Vitamin D supplements significantly improved post-COVID-19 symptoms in deficient patients.